{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:15:15Z","timestamp":1789384515396,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.ijpharm.2012.07.065","type":"journal-article","created":{"date-parts":[[2012,8,4]],"date-time":"2012-08-04T05:34:07Z","timestamp":1344058447000},"page":"80-82","source":"Crossref","is-referenced-by-count":26,"title":["A novel formulation of solubilised amphotericin B designed for ophthalmic use"],"prefix":"10.1016","volume":"437","author":[{"given":"D.R.","family":"Serrano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.K.","family":"Ruiz-Salda\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Molero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.","family":"Ballesteros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Torrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2012.07.065_bib0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijpharm.2008.05.013","article-title":"Effect of aggregation state on the toxicity of different amphotericin B preparations","volume":"361","author":"Espada","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.07.065_bib0010","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/bmc.947","article-title":"HPLC assay for determination of amphotericin B in biological samples","volume":"22","author":"Espada","year":"2008","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ijpharm.2012.07.065_bib0015","series-title":"European Pharmacopoeia","year":"2009"},{"key":"10.1016\/j.ijpharm.2012.07.065_bib0020","series-title":"Handbook of Pharmaceutical Excipients","year":"2009"},{"key":"10.1016\/j.ijpharm.2012.07.065_bib0080","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1089\/jop.2008.0031","article-title":"Development of effective ocular preparations of antifungal agents","volume":"24","author":"Kaur","year":"2008","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2012.07.065_bib0025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijpharm.2009.06.005","article-title":"Cyclodextrins as solubilizers: effects of excipients and competing drug","volume":"379","author":"Jansook","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.07.065_bib0030","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1034\/j.1600-0420.2002.800205.x","article-title":"Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye","volume":"80","author":"Loftsson","year":"2002","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.ijpharm.2012.07.065_bib0035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0169-409X(98)00055-6","article-title":"Cyclodextrins in ophthalmic drug delivery","volume":"36","author":"Loftsson","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2012.07.065_bib0045","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijpharm.2007.04.028","article-title":"Liposomal amphotericin B eye drops to treat fungal keratitis: physico-chemical and formulation stability","volume":"344","author":"Morand","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.07.065_bib0050","first-page":"1","article-title":"An insight into ophthalmic drug delivery system","volume":"1","author":"Rathore","year":"2009","journal-title":"Int. J. Pharm. Sci. Drug Res."},{"key":"10.1016\/j.ijpharm.2012.07.065_bib0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/10611860400006596","article-title":"Amphotericin B molecular organization as an essential factor to improve activity\/toxicity ratio in the treatment of visceral leishmaniasis","volume":"12","author":"S\u00e1nchez Brunete","year":"2004","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijpharm.2012.07.065_bib0060","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/sj.eye.6700557","article-title":"Fungal infections of the cornea","volume":"17","author":"Thomas","year":"2003","journal-title":"Eye"},{"key":"10.1016\/j.ijpharm.2012.07.065_bib0065","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1002\/jps.21179","article-title":"Amphotericin B formulations and drug targeting","volume":"97","author":"Torrado","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.07.065_bib0070","doi-asserted-by":"crossref","DOI":"10.1208\/pt040345","article-title":"Effect of hydroxypropyl beta cyclodextrin complexation on aqueous solubility, stability and corneal permeation of acyl ester prodrugs of ganciclovir","volume":"4","author":"Tirucherai","year":"2003","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2012.07.065_bib0075","series-title":"Drug Delivery and Targeting","article-title":"Opthalmic drug delivery","author":"Wilson","year":"2001"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312007867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312007867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T17:57:07Z","timestamp":1542823027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517312007867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":15,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0378517312007867"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2012.07.065","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}